Clicky

Novo Nordisk A/S(NOVO-B) News

Date Title
Jul 29 What Will Be the Best Weight Loss Drug Stock of 2030: Eli Lilly, or Novo Nordisk?
Jul 29 Is Trending Stock Novo Nordisk A/S (NVO) a Buy Now?
Jul 29 Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
Jul 29 Novo Nordisk A/S – Share repurchase programme
Jul 29 Swiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss
Jul 29 Zacks Market Edge Highlights: LLY and NVO
Jul 28 This Could Send Ozempic's Sales Potential to a Whole Other Level
Jul 27 Novo Nordisk's Next-Gen Diabetes Candidate Could Challenge Ozempic -- Is the Stock a Buy?
Jul 26 June PCE inflation print, auto earnings: Morning Brief
Jul 26 EMA backs Wegovy cardiovascular label update as Novo seeks EU coverage
Jul 26 Is Eli Lilly's Stock in a Bubble?
Jul 26 EU approves Novo Nordisk's Wegovy for heart, stroke treatment
Jul 26 Should You Invest in Novo Nordisk (NVO) Ahead of Q2 Earnings?
Jul 25 Why Weight Loss Drug Developer Stocks Tumbled on Thursday
Jul 25 Viking Therapeutics Unveils Monthly Weight-Loss Shot, Rocking Eli Lilly, Novo Nordisk
Jul 25 Why Viking’s Weight-Loss Drug News Is Weighing on Eli Lilly, Novo Nordisk Stocks
Jul 25 European regulatory authority adopts a positive opinion for an update of the Wegovy® label to reflect risk reduction of major adverse cardiovascular events
Jun 19 June 2024 Insights Into Three Stocks Estimated As Undervalued
Jun 18 Why the GLP-1 impact on other industries 'will take years'
Jun 18 New Weight-Loss Drugs and Devices Are Coming This Week